Chae Won Kim

8PUBLICATIONS
23CO-AUTHORS
Innate immunityCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2026
The efficacy of immunotherapy in glioma requires distal B cell responses in tumor-draining lymph nodes.

|May 22, 2025
Gut dysbiosis from high-salt diet promotes glioma via propionate-mediated TGF-β activation.

Chae Won Kim, Hyun-Jin Kim, In Kang

|Oct 26, 2024
Inhibitory Fcγ receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastoma.

Keun Bon Ku, Chae Won Kim, Yumin Kim

|Apr 07, 2023
Regulation of c-SMAC formation and AKT-mTOR signaling by the TSG101-IFT20 axis in CD4+ T cells.

Jiung Jeong, In Kang, Yumin Kim

|Oct 20, 2022
Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma.

Hyun-Jin Kim, Jang Hyun Park, Hyeon Cheol Kim

|Sep 15, 2021
Monocytes Contribute to IFN-β Production via the MyD88-Dependent Pathway and Cytotoxic T-Cell Responses against Mucosal Respiratory Syncytial Virus Infection.

Tae Hoon Kim, Chae Won Kim, Dong Sun Oh

Pageof 2

Frequent Collaborators

8 joint publications

Heung Kyu Lee

3 joint publications

Hyeon Cheol Kim

3 joint publications

Byeong Hoon Kang

3 joint publications

Jeongwoo La